PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,490.00
+29.00 (1.98%)
At close: Apr 24, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 30.93 billion as of April 24, 2026. Its market cap has decreased by -44.02% in one year.
Market Cap
30.93B
Enterprise Value
38.90B
Revenue
2.85B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,490.00
Market Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 30.93B, a decrease of -75.77%. That is a compound annual growth rate of -22.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 30.93B | 36.67% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 470.00B |
| 3billion | 379.55B |
| GENINUS | 180.89B |
| Cytogen | 113.73B |
| HLB Panagene | 106.17B |
| Green Cross Medical Science | 84.47B |
| Protia | 63.29B |
| Seoulin Bioscience | 57.29B |